Fund details
Series |
Currency |
Fund code |
MER * (%) |
---|---|---|---|
F | CAD | 35075 | 0.99% |
To provide long-term capital growth by investing in equity securities of European companies in order to provide exposure to growth opportunities in the European economy and diversification benefits beyond North America.
Series |
Currency |
Fund code |
MER * (%) |
---|---|---|---|
F | CAD | 35075 | 0.99% |
Top 10 Holdings |
% Assets |
---|---|
Allianz SE | 3.6% |
EssilorLuxottica SA | 3.2% |
Roche Holding AG | 2.8% |
ASML Holding NV | 2.8% |
Novo Nordisk A/S - Class B Shares | 2.7% |
Iberdrola SA | 2.7% |
Air Liquide SA | 2.7% |
London Stock Exchange Group PLC | 2.6% |
AstraZeneca PLC | 2.6% |
SAP SE | 2.6% |
Total % of Top 10 Holdings | 28.3% |
1 Mth | 3 Mth | 6 Mth | 1 year | 3 years | 5 years | 10 years | Since Inception | |||
---|---|---|---|---|---|---|---|---|---|---|
3.8 | 0.4 | 8.4 | 6.2 | 12.0 | 9.7 | 6.3 | 5.0 | Fund |
YTD* | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Total distributions | 0.52 | 1.12 | 1.00 | 0.46 | 1.62 | 0.41 | 0.48 | 1.09 | 1.20 | 0.59 | 0.28 |
Interest | --- | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | --- | --- | --- |
Canadian dividends | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
Foreign dividends | --- | 0.56 | 0.59 | 0.43 | 0.34 | 0.30 | 0.51 | 0.55 | 0.39 | 0.34 | 0.32 |
Foreign taxes paid | --- | -0.07 | -0.06 | -0.04 | -0.03 | -0.03 | -0.04 | -0.06 | -0.04 | -0.03 | -0.04 |
Capital gains | --- | 0.63 | 0.46 | 0.06 | 1.30 | 0.14 | --- | 0.60 | 0.85 | 0.28 | --- |
Return of capital | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.